State Street SPDR SandP Biotech ETF (XBI) |
| 136.69 0.7 (0.51%) 05-29 16:00 |
| Open: | 136.48 |
| High: | 137.345 |
| Low: | 135.61 |
| Volume: | 6,676,187 |
| Market Cap: | 8,505(M) |
| PE Ratio: | 0 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management - Global |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 161.30 |
| Resistance 1: | 138.10 |
| Pivot price: | 133.12 |
| Support 1: | 130.05 |
| Support 2: | 125.07 |
| 52w High: | 139.19 |
| 52w Low: | 79.49 |
T
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 29 May 2026
Is State Street SPDR S&P Semiconductor ETF (XSD) a Strong ETF Right Now? - Yahoo Finance
Thu, 28 May 2026
VHT vs. XBI: Vanguard Health Care ETF Tops SPDR Biotech in Yield and Cost - AOL.com
Thu, 28 May 2026
VHT vs. XBI: Vanguard Health Care ETF Tops SPDR Biotech in Yield and Cost - The Motley Fool
Wed, 27 May 2026
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
Fri, 08 May 2026
Is State Street SPDR S&P Homebuilders ETF (XHB) a Strong ETF Right Now? - Yahoo Finance
Wed, 22 Apr 2026
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
